Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris
Public ClinicalTrials.gov record NCT03322137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of SNA-120 (Pegcantratinib) Ointment in Subjects With Pruritus Associated With Psoriasis Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To characterize the efficacy, safety and tolerability of SNA-120 at 2 doses versus placebo when administered topically for the treatment of pruritus associated with psoriasis vulgaris (PV) and PV itself.
Study identification
- NCT ID
- NCT03322137
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 208 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 10, 2017 (Actual)
- Primary completion
- Sep 10, 2018 (Actual)
- Completion
- Oct 22, 2018 (Actual)
- Last update posted
- Feb 8, 2019
2017 – 2018
United States locations
- U.S. sites
- 38
- U.S. states
- 25
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 025 | Scottsdale | Arizona | 85255 | — |
| Sienna 022 | Fort Smith | Arkansas | 72916 | — |
| Site 028 | Fountain Valley | California | 92708 | — |
| Sienna 009 | Fremont | California | 94538 | — |
| Sienna 008 | San Diego | California | 92123 | — |
| Sienna 020 | Santa Monica | California | 90404 | — |
| Sienna 015 | Denver | Colorado | 80220 | — |
| Sienna 005 | Farmington | Connecticut | 06032 | — |
| Site 030 | Shelton | Connecticut | 06484 | — |
| Site 026 | Doral | Florida | 33122 | — |
| Sienna 019 | Largo | Florida | 33770 | — |
| Sienna 017 | North Miami Beach | Florida | 33162 | — |
| Sienna 024 | Ocala | Florida | 34471 | — |
| Site 027 | West Palm Beach | Florida | 33406 | — |
| Site 029 | Macon | Georgia | 31217 | — |
| Sienna 010 | New Albany | Indiana | 47150 | — |
| Sienna 011 | Plainfield | Indiana | 46168 | — |
| Sienna 023 | Louisville | Kentucky | 40202 | — |
| Site 038 | Metairie | Louisiana | 70006 | — |
| Site 032 | Rockville | Maryland | 20850 | — |
| Site 039 | Clarkston | Michigan | 48346 | — |
| Sienna 002 | Fridley | Minnesota | 55432 | — |
| Sienna 001 | St Louis | Missouri | 63117 | — |
| Sienna 004 | East Windsor | New Jersey | 08520 | — |
| Sienna 013 | Albuquerque | New Mexico | 87106 | — |
| Site 037 | Rochester | New York | 14623 | — |
| Sienna 016 | High Point | North Carolina | 27626 | — |
| Sienna 006 | Winston-Salem | North Carolina | 27104 | — |
| Site 041 | Norman | Oklahoma | 73071 | — |
| Sienna 003 | Portland | Oregon | 97223 | — |
| Site 031 | Pittsburgh | Pennsylvania | 15213 | — |
| Site 035 | Murfreesboro | Tennessee | 37130 | — |
| Sienna 012 | Austin | Texas | 78759 | — |
| Sienna 021 | Dallas | Texas | 75246 | — |
| Sienna 018 | Houston | Texas | 77030 | — |
| Site 034 | Pflugerville | Texas | 78660 | — |
| Sienna 007 | Murray | Utah | 84107 | — |
| Sienna 014 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03322137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03322137 live on ClinicalTrials.gov.